Yi ZF - Search Results

1

The small-molecule drug homoharringtonine targets HSF1 to suppress pancreatic cancer progression.

Li GH, Miao Y, Chen H, Xue MF, Wang JY, Zhang JW, Yi ZF, Sun ZL. Li GH, et al. Among authors: yi zf. Am J Cancer Res. 2024 May 15;14(5):2072-2087. doi: 10.62347/XFJH3424. eCollection 2024. Am J Cancer Res. 2024. PMID: 38859866 Free PMC article.

2

Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.

Pang X, Yi T, Yi Z, Cho SG, Qu W, Pinkaew D, Fujise K, Liu M. Pang X, et al. Cancer Res. 2009 Jan 15;69(2):518-25. doi: 10.1158/0008-5472.CAN-08-2531. Cancer Res. 2009. PMID: 19147565 Free PMC article.

3

Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, Liu M. Pang X, et al. Cancer Res. 2009 Jul 15;69(14):5893-900. doi: 10.1158/0008-5472.CAN-09-0755. Epub 2009 Jun 30. Cancer Res. 2009. PMID: 19567671 Free PMC article.

4

Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway.

Pang X, Yi Z, Zhang J, Lu B, Sung B, Qu W, Aggarwal BB, Liu M. Pang X, et al. Cancer Res. 2010 Mar 1;70(5):1951-9. doi: 10.1158/0008-5472.CAN-09-3201. Epub 2010 Feb 16. Cancer Res. 2010. PMID: 20160026 Free PMC article.

5

Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.

He L, Wu Y, Lin L, Wang J, Wu Y, Chen Y, Yi Z, Liu M, Pang X. He L, et al. Cancer Sci. 2011 Jan;102(1):219-25. doi: 10.1111/j.1349-7006.2010.01778.x. Epub 2010 Nov 19. Cancer Sci. 2011. PMID: 21087351 Free article.

6

LG308, a Novel Synthetic Compound with Antimicrotubule Activity in Prostate Cancer Cells, Exerts Effective Antitumor Activity.

Qin M, Peng S, Liu N, Hu M, He Y, Li G, Chen H, He Y, Chen A, Wang X, Liu M, Chen Y, Yi Z. Qin M, et al. J Pharmacol Exp Ther. 2015 Dec;355(3):473-83. doi: 10.1124/jpet.115.225912. Epub 2015 Sep 16. J Pharmacol Exp Ther. 2015. PMID: 26377911

7

A hybrid of thiazolidinone with the hydroxamate scaffold for developing novel histone deacetylase inhibitors with antitumor activities.

Yang F, Peng S, Li Y, Su L, Peng Y, Wu J, Chen H, Liu M, Yi Z, Chen Y. Yang F, et al. Org Biomol Chem. 2016 Feb 7;14(5):1727-35. doi: 10.1039/c5ob02250a. Org Biomol Chem. 2016. PMID: 26732459

8

Synthesis and biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosterone derivatives as antitumor agents.

Cui HW, Peng S, Gu XZ, Chen H, He Y, Gao W, Lv F, Wang JH, Wang Y, Xie J, Liu MY, Yi Z, Qiu WW. Cui HW, et al. Eur J Med Chem. 2016 Mar 23;111:126-37. doi: 10.1016/j.ejmech.2016.01.058. Epub 2016 Feb 1. Eur J Med Chem. 2016. PMID: 26866967

9

Novel 3,4-seco bile acid diamides as selective anticancer proliferation and migration agents.

Mao SW, Chen H, Yu LF, Lv F, Xing YJ, Liu T, Xie J, Tang J, Yi Z, Yang F. Mao SW, et al. Eur J Med Chem. 2016 Oct 21;122:574-583. doi: 10.1016/j.ejmech.2016.04.055. Epub 2016 May 24. Eur J Med Chem. 2016. PMID: 27448915

10

Discovery and Optimization of N-Substituted 2-(4-pyridinyl)thiazole carboxamides against Tumor Growth through Regulating Angiogenesis Signaling Pathways.

Zhou W, Tang W, Sun Z, Li Y, Dong Y, Pei H, Peng Y, Wang J, Shao T, Jiang Z, Yi Z, Chen Y. Zhou W, et al. Sci Rep. 2016 Sep 16;6:33434. doi: 10.1038/srep33434. Sci Rep. 2016. PMID: 27633259 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters